Fish analysis at diagnosis in acute lymphoblastic leukemia

Area of Science:

• Hematology
• Genetics
• Oncology

Background:

• Cytogenetic abnormalities in acute lymphoblastic leukemia (ALL) significantly impact patient prognosis.
• Specific chromosomal changes like hyperdiploidy and t(12;21) indicate favorable outcomes, while t(9;22) and 11q23 rearrangements suggest a poor prognosis.
• Accurate and rapid detection of these abnormalities at diagnosis is essential for effective treatment strategies.

Purpose of the Study:

• To evaluate the utility of fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH) for the accurate and rapid detection of key cytogenetic abnormalities in ALL.
• To establish a FISH-based approach as a complementary diagnostic tool to conventional cytogenetics for ALL patients.

Main Methods:

• Utilized FISH with specific probes for detecting structural rearrangements: t(9;22), t(12;21), and 11q23 rearrangements directly on interphase cells.
• Employed CGH for the detection of hyperdiploidy, characterizing chromosomal gains and losses without the need for metaphase acquisition.
• Applied these molecular techniques to analyze ALL patient samples at diagnosis.

Main Results:

• Demonstrated that the FISH-based approach accurately identifies specific prognostic chromosomal abnormalities in ALL.
• Showed that CGH effectively detects hyperdiploidy, a favorable prognostic indicator.
• Confirmed that the combined FISH and CGH methodology is complementary to conventional cytogenetics.

Conclusions:

• The FISH and CGH-based approach provides accurate and rapid detection of critical cytogenetic abnormalities in acute lymphoblastic leukemia.
• This molecular diagnostic strategy enhances prognostic assessment and aids in treatment decisions for ALL patients.
• Systematic implementation of this FISH-based approach alongside conventional cytogenetics is recommended for ALL diagnosis.